Legeviten > Onkologi
NEW YORK (Reuters Health) - Taking a multivitamin is unlikely to help colon cancer patients in battling the disease, suggests a new study.
(www.merckmedicus.com)
[10.09.2010 02:45]
|
Helseministeren lot seg imponere
Les mer »
Helse- og omsorgsminister Anne-Grete Strøm Erichsen besøkte onsdag 8. september Sykehuset i Vestfold. Ministeren vær tydelig imponert over virksomheten både på Kysthospitalet og i Tønsberg.
(www.siv.no) |
|
a proprietary blood-based technology currently being developed for earlier, more accurate and less invasive testing for cancer and other complex diseases.
Les mer »
"I am excited to have both these demonstrated leaders join our team, as they will immediately contribute to Caris' efforts to provide patients in Europe innovative, cost-effective and highly-accurate testing services," said Dominic P. Moorhead, President European Operations. "With the Carisome Platform and Caris Target Now, Caris Life Sciences will deliver truly personalized medicine to the European health systems, and these additions to our team will help build the momentum."
(hopey.netfonds.no) |
|
Elekta Customers See Their Ideas Brought to Life at ESTRO 29
Les mer »
- Unique Hologram Theatre Shows Translation of Customer Input into Practical Clinical Solutions
(www.pressemeldinger.no) |
) Discontinuation of sale of ceftobiprole in Switzerland
Les mer »
Basilea Pharmaceutica AG / Discontinuation of sale of ceftobiprole in Switzerland processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
(hopey.netfonds.no) |
|
Om Univer sitetsdjursjukhuset
Les mer »
Den 1 januari 2007 startade Univer sitetsdjursjukhuset, UDS, vid Sveriges lantbruksuniversietet, SLU, i Uppsala.
(www.slu.se) |
|
) GSK and Genmab Announce Start of Ofatumumab Phase III Combination Study in Non-Hodgkin's Lymphoma
Les mer »
Summary: GSK and Genmab announce the initiation of a Phase III study of ofatumumab in rituximab refractory patients with indolent B-cell non-Hodgkin's Lymphoma.
(hopey.netfonds.no) |
GSK and Genmab Announce Start of Ofatumumab Phase III Combination Study in Non-Hodgkin's Lymphoma (September 08, 2010)
Les mer »
LONDON and COPENHAGEN, Denmark, Sept. 8, 2010 (GLOBE NEWSWIRE) -- Summary: GSK and Genmab announce the initiation of a Phase III study of ofatumumab in rituximab refractory patients with indolent B-cell non-Hodgkin's Lymphoma.
(digitalproducer.digitalmedianet.com) |
|
Cyclacel to Present at Annual Rodman & Renshaw Healthcare Conference (September 08, 2010)
Les mer »
The presentation will be webcast live and archived for 90 days on the Corporate Presentations page of the Cyclacel website at
(digitalproducer.digitalmedianet.com) |
Rexahn Pharmaceuticals, Inc. to Present at the
Les mer »
ROCKVILLE, Md.--(BUSINESS WIRE)--Rexahn Pharmaceuticals, Inc.
(www.biospace.com) |
|
TapImmune Appoints New Personnel to Board of Directors and Advisory Team
Les mer »
, Founder and Managing Partner, Sherbrook Capital Management.
(digitalproducer.digitalmedianet.com) |
US Oncology Selects Self-Service Solutions from PatientPoint
Les mer »
PatientPoint, a provider of multi-channel self-service applications for the healthcare industry, today announced that US Oncology, the leading integrated oncology company supporting more than 1,300 affiliated physicians in 500 locations throughout 39 states, has selected PatientPoint solutions to provide self-service technologies to enhance the patient experience.
(digitalproducer.digitalmedianet.com) |
|
08/09-2010 14:15:00: Invitation: Elekta´s Interim Report May-July 2010/11
Les mer »
The report will be published on September 21, at around 13.00 CET.
(hopey.netfonds.no) |
|
ICU Medical, Inc. to Present at Two Investor Conferences in September
Les mer »
Annual Healthcare Conference to be held on September 12-15 at the New York Palace Hotel in New York. The presentation will take place on Tuesday, September 14, at 10:00 AM Eastern Time.
(digitalproducer.digitalmedianet.com) |
|
Tekmira Pharmaceuticals Corporation Receives Clearance From
Les mer »
), a leader in RNA interference (RNAi) therapeutics, today announced that its Investigational New Drug (IND) application for TKM-PLK1 has been cleared by the United States Food and Drug Administration (FDA) allowing Tekmira to initiate a Phase 1 human clinical trial.
(www.biospace.com) |
|
biOasis Presents Research Results on Transcend(TM) at International Symposium on the Blood-Brain Barrier
Les mer »
VANCOUVER, British Columbia, Sept.
(digitalproducer.digitalmedianet.com) |
|
IRIS to Present at UBS Annual Global Life Sciences Conference
Les mer »
Garcia will also be available for one-on-one meetings with institutional investors at the conference on Monday, September 20 and Tuesday, September 21.
(digitalproducer.digitalmedianet.com) |
|
Celldex Therapeutics, Inc. (
Les mer »
/PRNewswire-FirstCall/ -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today it will regain full worldwide rights to develop and commercialize rindopepimut (CDX-110), effective
(www.biospace.com) |
|
) Algeta's financial calendar 2011
Les mer »
Oslo, Norway, 6 September 2011 - Algeta ASA (OSE: ALGETA), the focused oncology company, announces its financial calendar for 2011
(hopey.netfonds.no) |
|
Alcohol intake increases certain types of breast cancer
Les mer »
Alcohol increases the risk of lobular and hormone receptor-positive breast cancer, but not necessarily invasive ductal carcinomas, according to a study published August 23 online in The Journal of the National Cancer Institute (see also Breast Cancer).
(www.merckmedicus.com) |
Virtual colonoscopies help identify additional cancers outside of the colon, study suggests
Les mer »
Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved, according to a study in the September issue of the American Journal of Roentgenology (www.ajronline.org).
(www.merckmedicus.com) |
|
Consolidative radiation improves survival with aggressive B-cell lymphoma
Les mer »
NEW YORK (Reuters Health) - In diffuse large B-cell lymphoma, radiation after R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) improves overall and progression-free survival, a new report shows.
(www.merckmedicus.com) |
|
Electronic tracking system can improve follow-up after an abnormal Pap test
Les mer »
(Boston) - Researchers from Boston University School of Medicine (BUSM) report that physicians who use an automated, electronic medical record (EMR) tracking system to follow-up on patients with an abnormal Pap test could increase the number of women who achieved diagnostic resolution and have women achieve resolution in less time than using traditional methods.
(www.merckmedicus.com) |
Neoadjuvant chemo often bests primary surgery for advanced ovarian CA
Les mer »
NEW YORK (Reuters Health) - Debulking is the standard first-line approach to advanced ovarian cancer, but starting with chemotherapy before surgery doesn't hurt survival - and in fact has some benefits, a multinational team reports September 2nd in the New England Journal of Medicine.
(www.merckmedicus.com) |
|
Vitamin D linked to autoimmune and cancer disease genes, underscoring risks of deficiency
Les mer »
Vitamin D deficiency, resulting from either lack of sun exposure or poor dietary intake, is increasingly being recognized as a risk factor for a number of serious illnesses, and has been linked with autoimmune conditions such as multiple sclerosis, type 1 diabetes, and rheumatoid arthritis.
(www.merckmedicus.com) |
MorphoSys AG Initiates Program With
Les mer »
MorphoSys AG / MorphoSys Initiates Program Against Drug-Resistant MRSA Infections processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement.
(www.biospace.com) |
|
02/09-2010 18:00:00: Number of shares in Elekta
Les mer »
During August, 195,575 new B shares were issued in Elekta through the exercise of warrants distributed within the framework of the established option program.`
(hopey.netfonds.no) |
|
Samlet inn 417 luer til kreftsyke
Les mer »
I april spurte konst. oversykepleier Heidi Sagdahl Radlgruber (KBK) om strikke- og bloggeentusiast Margot Viste Forskningsavdelingen) hadde flere strikkeluer på lager. Tirsdag 1. september kom "svaret": To stappfulle bæreposer med luer til kreftpasienter fra strikkende ildsjeler over hele landet.
(www.helse-stavanger.no) |
Gallbladder cancer may be linked to estrogens, says UH team
Les mer »
A very aggressive disease with a poor prognosis, gallbladder cancer may be connected to higher exposure to estrogens, according to a group of researchers at the University of Houston (UH).
(www.merckmedicus.com) |
|Om Viddi.no | Kontakt oss på tommy (a) viddi.no | Copyright® - 2006 Viddinews AS |